Long-acting coagulation factor vii and methods of producing same
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- OPKO BIOLOGICS
- Publication Date
- 2019-04-02
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] Polypeptides comprising at least one carboxy-terminal peptide (CTP) of chorionic gonadotropin linked to the carboxy-terminus of a coagulation factor and polynucleotides encoding the polypeptides are disclosed. Also disclosed are pharmaceutical compositions and pharmaceutical formulations comprising the polypeptides and polynucleotides of the disclosure and methods of using and producing them. Background technique
[0002] The development of clotting factor replacement therapy has changed the lives of many individuals with hemophilia. Hemophilia is a group of inherited genetic disorders that impair the body's ability to control blood clotting, or clotting. People with hemophilia do not produce sufficient amounts of the Factor VIII or Factor IX proteins, which are necessary for effective blood clotting. In people with severe hemophilia, even minor injuries can cause blood loss for days or weeks, and complete healing may not occur, leading to possible p...